Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-17T11:09:19.894Z Has data issue: false hasContentIssue false

Case Report : Ongoing Delirium and Hypercalcaemia in a Patient With Bipolar Disorder Receiving Long Term Lithium Therapy

Published online by Cambridge University Press:  30 June 2026

Mohamed Fareeth
Affiliation:
Trakia University, Stara Zagora, Bulgaria
Hafijur Rahman
Affiliation:
Trakia University, Stara Zagora, Bulgaria
Fathima Zainab
Affiliation:
European University, Tiblisi, Georgia
Inaam Alam
Affiliation:
Plovdiv University, Plovdiv, Bulgaria
Abdul Gafoor Mohamed Fareeth
Affiliation:
King AbdulAziz, Al Ahsa, Saudi Arabia
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Aims:

Lithium is a first-line mood stabiliser for bipolar disorder but has a narrow therapeutic index. Neuropsychiatric toxicity may occur even when serum lithium concentrations are near the therapeutic range, particularly in the presence of dehydration and acute kidney injury. This case study aims to highlight lithium-associated neuropsychiatric toxicity as an important and potentially overlooked cause of ongoing delirium in patients with bipolar disorder following acute medical illness.

Methods:

A 74-year-old woman with bipolar disorder treated with long-term lithium therapy was admitted following collapse and acute onset confusion. On presentation, she was febrile, dehydrated, and disoriented, with clinical evidence of cellulitis, leading to an initial diagnosis of acute delirium secondary to sepsis. She was treated empirically with intravenous antibiotics and fluids. Despite improved inflammatory markers, her neuropsychiatric symptoms persisted.

Further investigations revealed mild hypernatraemia, persistent hypercalcaemia, acute kidney injury, and a mildly elevated serum lithium level but her parathyroid hormone levels were within the normal limit. CT and MRI of the brain revealed no acute intracranial pathology. Despite rehydration and resolution of infection, delirium and biochemical abnormalities persisted, prompting review of psychotropic medication.

Results:

Lithium toxicity precipitated by dehydration and acute kidney injury was identified as the most likely unifying diagnosis. Lithium dosage was reduced and intravenous bisphosphonate therapy was administered. Following intervention, renal function improved and serum lithium and calcium concentrations normalised. The patient demonstrated gradual and complete resolution of delirium, returning to her cognitive baseline without residual neuropsychiatric impairment at discharge.

This case illustrates that lithium-associated neuropsychiatric toxicity may present with persistent delirium despite near-therapeutic serum levels and apparent alternative medical explanations. Hypercalcaemia and renal impairment served as important diagnostic clues supporting lithium toxicity.

Conclusion:

Lithium toxicity should be considered in patients with bipolar disorder who develop persistent delirium, particularly when dehydration and acute kidney injury are present. Near-therapeutic serum lithium levels do not exclude clinically significant neurotoxicity. Early review of psychotropic medication and renal function is essential to prevent delayed diagnosis and avoidable morbidity.

Information

Type
Psychopharmacology
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of Royal College of Psychiatrists
Submit a response

eLetters

No eLetters have been published for this article.